Nanotechnology in Stroke: New Trails with Smaller Scales

Nanotechnology in Stroke: New Trails with Smaller Scales

Stroke is a leading cause of death, long-term disability, and socioeconomic costs, highlighting the urgent need for effective treatment. During acute phase, intravenous administration of recombinant tissue plasminogen activator (tPA), a thrombolytic agent, and endovascular thrombectomy (EVT), a mech...

Full description

Bibliographic Details
Main Authors: Karlo Toljan, Anushruti Ashok, Vinod Labhasetwar, M. Shazam Hussain
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Biomedicines
Subjects:
nanoparticles
drug delivery
thrombolysis
drug targeting
reperfusion injury
oxidative stress
Online Access:https://www.mdpi.com/2227-9059/11/3/780

Internet

https://www.mdpi.com/2227-9059/11/3/780

Similar Items